Association between antiseizure medications and quality of life in epilepsy: A mediation analysis
Open Access
- 20 December 2021
- Vol. 63 (2) , 440-450
Abstract
Objective The relationship between antiseizure medications (ASMs), which improve health outcomes by controlling seizures, and health-related quality of life (HRQOL) is poorly understood and may involve intermediate variables. We evaluated the potential mediators of the association between ASMs and HRQOL. Methods Data are from an outpatient registry of adult patients with epilepsy seen at the Foothills Medical Center, Calgary, Alberta, Canada. Quality of life was measured using the 10-item Quality of Life in Epilepsy, and depression was measured using the Neurological Disorders Depression Inventory for Epilepsy. Propensity score matching was used to adjust for covariate imbalance between patients who received a single ASM (monotherapy) and those who received two or more ASMs (polytherapy) due to confounding. Mediation analysis was used to estimate the mediating effects of depression and ASM side effects on the association between patients' ASM polytherapy and HRQOL. Results Of 778 patients included in this analysis, 274 (35.2%) were on two or more ASMs. Patient-reported depression and ASM side effects jointly mediated the association between ASMs and HRQOL; these mediators accounted for 42% of the total average effect of ASM polytherapy ( = −13.6, 95% confidence interval = −18.2 to −8.6) on HRQOL. Significance These findings highlight the importance of managing depression and ASM side effects for improving health outcomes of patients requiring treatment with ASMs. Intervention programs aimed at improving HRQOL of patients with epilepsy need to target these potential mediators.
Keywords
This publication has 35 references indexed in Scilit:
- Depression in epilepsyNeurology, 2013
- Reliability and validity of the Korean version of the Neurological Disorders Depression Inventory for Epilepsy (K-NDDI-E)Epilepsy & Behavior, 2012
- Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010The Lancet, 2012
- Self reported adverse effects of mono and polytherapy for epilepsySeizure: European Journal of Epilepsy, 2012
- Screening for major depressive episodes in Japanese patients with epilepsy: Validation and translation of the Japanese version of Neurological Disorders Depression Inventory for Epilepsy (NDDI-E)Epilepsy & Behavior, 2012
- Development of an epilepsy-specific risk adjustment comorbidity indexEpilepsia, 2011
- Matching as Nonparametric Preprocessing for Reducing Model Dependence in Parametric Causal InferencePolitical Analysis, 2007
- Frequent seizures and polytherapy can impair quality of life in persons with epilepsyNeurology India, 2005
- The ILAE/IBE/WHO Epilepsy Global Campaign HistoryEpilepsia, 2002
- A Brief Questionnaire to Screen for Quality of Life in Epilepsy The QOLIE‐10Epilepsia, 1996